San Diego, CA, United States of America

Timothy W Lovenberg

This inventor holds 30 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents, primarily in Histamine Receptor Research. Top assignees: Ortho-Mcneil Pharmaceutical Corp., Janssen Pharmaceutica Nv, Ortho Pharmaceutical Corporation. Active years: 1999-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy W Lovenberg. Retrieved from https://idiyas.com/inventor/timothy-w-lovenberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 

% Patents Active = 73.3



Average Co-Inventor Count = 3.7

ph-index = 7

Forward Citations = 180(Granted Patents)


Company Filing History:


Years Active: 1999-2012

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Hexahydro-Pyrrolo-Isoquinoline Compounds
GPR81 Receptors
Aryl Piperidine Amides
Relaxin-3 Polypeptides
Histamine Receptor H3
Neuropeptide Y
Amino Pyrazole Derivatives
Obesity Treatment
Transgenic Mice
H3 Antagonists
Ligands
Non-Peptidic Inhibitors
30 patents (USPTO):Explore Patents

Title: **Timothy W. Lovenberg: Innovator in Pharmaceutical Patents**

Introduction

Timothy W. Lovenberg, based in San Diego, CA, is a notable inventor with a significant contribution to the field of pharmaceuticals. He holds an impressive portfolio of 30 patents, reflecting his innovative efforts in drug development and therapeutic mechanisms.

Latest Patents

His latest inventions include groundbreaking patents focused on hexahydro-pyrrolo-isoquinoline compounds. These compounds have been identified as histamine H receptor and serotonin transporter modulators, which are promising for the treatment of diseases associated with these mechanisms. In addition, he has developed methods for identifying modulators of GPR81 receptors. This innovation utilizes complexes of GPR81 receptor components and ligand components, like L-lactate or GHB, as assay reagents for screening GPR81 receptor activity modulators.

Career Highlights

Throughout his career, Timothy has made significant strides while working at reputable organizations such as Ortho-McNeil Pharmaceutical Corporation and Janssen Pharmaceutica NV. His work in these companies has been instrumental in advancing pharmaceutical research and developing innovative therapies.

Collaborations

Timothy has also collaborated with esteemed professionals in the pharmaceutical field, including Nicholas I. Carruthers and Mark G. Erlander. These collaborations have enhanced his work and contributed to the successful development of various inventive solutions.

Conclusion

In conclusion, Timothy W. Lovenberg is a remarkable inventor whose contributions have made a meaningful impact in the pharmaceutical industry. His commitment to innovation and collaboration underscores the significance of teamwork in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…